NEW

MITA Urges Regulatory Changes to Get Mobile Imaging to Emergency COVID-19 Pandemic Hospitals

The Medical Imaging & Technology Alliance (MITA) today sent a letter to the Food and Drug Administration (FDA) outlining key steps the agency can take to help the medical imaging industry swiftly and thoroughly aid the response to the COVID-19 pandemic. Addressed...

FDA Shares Coronavirus (COVID-19) Update

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: FDA-ARGOS SARS-CoV-2 Reference Grade Sequence Data Now Available: In response to the COVID-19 pandemic, the FDA—in collaboration...

FDA: MQSA Inspection Information Related to COVID-19

The Division of Mammography Quality Standards (DMQS) has received numerous inquiries regarding COVID-19 and its increasing impact on mammography facilities. The FDA has temporarily postponed domestic inspections including ones performed under contract with its state...

3M Outlines Latest Actions on COVID-19 Response

3M Chairman and CEO Mike Roman issued the following update announcing additional details about 3M’s capacity increases of N95 respirators, strong measures to combat price gouging and counterfeiting, and new partnerships to help protect our healthcare workers on the...